1. Home
  2. ICL vs ALKS Comparison

ICL vs ALKS Comparison

Compare ICL & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ICL Group Ltd.

ICL

ICL Group Ltd.

HOLD

Current Price

$5.02

Market Cap

6.6B

Sector

Industrials

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$52.52

Market Cap

7.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICL
ALKS
Founded
1968
1987
Country
Israel
Ireland
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
7.5B
IPO Year
2001
2012

Fundamental Metrics

Financial Performance
Metric
ICL
ALKS
Price
$5.02
$52.52
Analyst Decision
Hold
Buy
Analyst Count
2
14
Target Price
$6.10
$43.43
AVG Volume (30 Days)
1.3M
2.4M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
3.31%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,475,899,000.00
Revenue This Year
$6.04
$24.26
Revenue Next Year
$3.27
$4.47
P/E Ratio
$31.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.76
$25.17
52 Week High
$7.35
$55.28

Technical Indicators

Market Signals
Indicator
ICL
ALKS
Relative Strength Index (RSI) 31.00 74.50
Support Level $4.84 $27.65
Resistance Level $5.59 N/A
Average True Range (ATR) 0.11 2.02
MACD -0.06 0.77
Stochastic Oscillator 9.77 77.99

Price Performance

Historical Comparison
ICL
ALKS

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates revenue from Brazil, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: